Abstract
Background
It is generally accepted that the efficacy with an intragastric balloon decreases after the first 4 months of treatment. Aim of this study is to evaluate if the association of a very low-calorie ketogenic diet (VLCKD) can improve the results in terms of weight loss parameters and co-morbidities, as compared to usually prescribed low-calorie diet (LCD).
Methods
For the present study (January 2016–June 2017), 80 patients (20 M/60 F, mean age 37.8 ± 6.1 years; excess weight 56 ± 10 kg; mean BMI 37.2 ± 3.8 kg/m2) underwent Orbera positioning. After 4 months, they were randomized into two groups according to the type of treatment: group A (Bioenterics intragastric balloon – Orbera + VLCKD) (n = 40), and group B (Orbera + LCD) (n = 40).
Results
All patients completed the study with good adherence to diet therapy treatment allocation. After the 6-month treatment period, at time of Orbera removal, mean weight loss was 19 kg and 12 kg in groups A and B respectively (p < 0.05). Mean BMI was 28.9 ± 2.8 and 31.6 ± 3.1 kg/m2 (p < 0.05), and %EWL was 33.1 ± 3.3 and 21.1 ± 2.9 (p < 0.05) in groups A and B respectively. During the last 2 months in group A, the mean weight loss was 8 kg, while in Group B, the main weight loss was 3 kg (p < 0.001). The VLCKD treatment induced a more significant reduction of major comorbidities related to metabolic syndrome.
Conclusions
This study clearly indicates the efficacy of the prescription of very low-calorie ketogenic diet improving the efficacy of intragastric balloon positioning.
Similar content being viewed by others
References
Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–6.
Dumonceau LM. Evidence based review of the bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611–7.
Genco A, Cipriano M, Bacci V, et al. Bioenterics intragastric balloon (BIB): a short term, double-blind, randomized, controller, crossover study on weight reduction in morbidly obese patients. Int J Obes. 2006;30:129–33.
Lorenzo M, Genco A, Intragastric balloon for the treatment of morbid obesity. In (Preedy VR, Rajendram R. Intragastric Balloon for the Treatment of Morbid Obesity. In: Martin CR, editor. Metabolism and pathophysiology of bariatric surgery. London: Academic Press; 2017. p. 139–46.
Alfalah H, Philippe B, Ghazal F, et al. Intragastric balloon for preoperative weight reduction in candidates for laparoscopic gastric bypass with massive obesity. Obes Surg. 2006;16:147–50.
Gottig S, Weiner RA, Daskalakis M. Preoperative weight reduction using the intragastric balloon. Obes Facts. 2009;2(suppl.1):20–3.
Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics intragastric balloon (BIB). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg. 2011;21:5–9.
Genco A, Cipriano M, Bacci V, et al. Intragastric balloon followed by diet vs intragastric balloon followed by another balloon. A prospective study on 100 patients. Obes Surg. 2010;20(11):1096–500.
Spyropoulos C, Katsakoulis E, Mead N, et al. Intragastric balloon for high risk superopbese patients: a prospective analysis of efficacy. Surg Obes Relat Dis. 2007;3:78–83.
Genco A, Balducci S, Bacci V, et al. Intragastric balloon or diet alone? A retrospective evaluation. Obes Surg. 2008;18:989–92.
Sumithran AI, Prendergast LA, Delbridge E, et al. Ketosis and appetite-mediating nutrients and hormones after weight loss. Eur J Clin Nutr. 2013;67:759–64.
NIH Conference. Gastrointestinal surgery for severe obesity. Consensus development conference panel. Ann Intern Med. 1991;115:956–61.
Messina T, Genco A, Favaro R, et al. Intragastric balloon positioning and removal: sedation or general anesthesia? Surg Endosc. 2011;25:3811–4.
Alberti KG, Zimmet P, Ahaw J. Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.
Angrisani L, Lorenzo M, Borrelli V, et al. Is bariatric surgery necessary after intragastric balloon treatment? Obes Surg. 2006;16:1135–7.
Genco A, Maselli R, Cipriano M, et al. Long-term multiple intragastric balloon treatment – a new strategy to treat morbid obese patients refusing surgery: prospective 6-year follow up study. Surg Obes Relat Dis. 2014;10:307–12.
Genco A, Bruni T, Doldi SB, et al. BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4.
Machytka E, Klvana P, Kornbluth A, et al. Adjustable intragastric balloons: a 12-months pilot trial in endoscopic weight loss management. Obes Surg. 2011;21:1499–507.
De la Riva S, Munoz-Navas M, Rodriguez-Lago I, et al. Small bowel migration: possible complication of adjustable intragastric balloon. Endoscopy. 2012;44:E224.
Genco A, Delle Piane D, Baglio G, et al. Adjustable intragastric balloon vs non-adjustable intragastric balloon: case-control study on complications, tolerance, and efficacy. Obes Surg. 2013;23:953–8.
Bueno NB, de Melo ISV, de Oliveira SL. Very low carbohydrate iatrogenic diet v. low-fat diet for long term weight loss a meta-analysis of randomised controlled trials. Br J Nutr. 2013;110:1178–87.
Leonetti F, Campanile FC, Coccia F, et al. Very low carbohydrate ketogenic diet before bariatric surgery: prospective evaluation of sequential diet. Obes Surg. 2015;25:64–71.
Moreno B, Bellido D, Sajoux I, et al. Comparison of a very low calories ketogenic diet with a standard low calories diet in the treatment of obesity. Endocrin. 2014;47:793–805.
Westerterp-Plantenga MS, Lemmens SG, Westerterm KR. Dietary protein – its role in satiety, energetics, weight loss and health. Br J Nutr. 2012;108(suppl 2):S105–12.
Willet WC, Manson JE, Stampfer MJ, et al. Weight, weight change, and coronary heart disease in women. JAMA. 1995;273:461–5.
Chan JM, Rimm EB, Colditz GA, et al. Weight gain as a risk factor for clinical diabetes in men. Diabetes Care. 1994;17:961–9.
Goday A, Bellido D, Sajoux J, et al. Short term safety, tolerability and efficacy of a very low calories ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutr Diab. 2016;6:1–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Genco, A., Ienca, R., Ernesti, I. et al. Improving Weight Loss by Combination of Two Temporary Antiobesity Treatments. OBES SURG 28, 3733–3737 (2018). https://doi.org/10.1007/s11695-018-3448-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-018-3448-9